These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6891930)

  • 21. Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu.
    Harris AL; Nicholson S; Sainsbury JR; Farndon J; Wright C
    J Steroid Biochem; 1989; 34(1-6):123-31. PubMed ID: 2576295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
    Anderson ED; Forrest AP; Levack PA; Chetty U; Hawkins RA
    Br J Cancer; 1989 Aug; 60(2):223-6. PubMed ID: 2527549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oestrogen receptors, nodes and stage as predictors of post-recurrence survival in 457 breast cancer patients.
    Shek LL; Godolphin W; Spinelli JJ
    Br J Cancer; 1987 Dec; 56(6):825-9. PubMed ID: 3435707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variations in steroid receptor status with disease stage in breast cancer.
    Stebbings WS; Anderson E; Puddefoot JR; Vinson GP; Gilmore OJ; Plowman PN
    Eur J Surg Oncol; 1989 Aug; 15(4):322-7. PubMed ID: 2759250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro clonogenic growth and metastatic potential of human operable breast cancer.
    Nomura Y; Tashiro H; Hisamatsu K
    Cancer Res; 1989 Oct; 49(19):5288-93. PubMed ID: 2766296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.
    Markkula A; Simonsson M; Ingvar C; Rose C; Jernström H
    BMC Cancer; 2014 Oct; 14():759. PubMed ID: 25305747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. A univariate and multivariate analysis of 3089 Japanese patients with breast cancer from the Study Group for the Japanese Breast Cancer Society on Hormone Receptors and Prognosis in Breast Cancer.
    Nomura Y; Miura S; Koyama H; Enomoto K; Kasumi F; Yamamoto H; Kimura M; Tominaga T; Iino H; Morimoto T
    Cancer; 1992 Jan; 69(1):153-64. PubMed ID: 1727658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
    Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence.
    Kamby C; Rasmussen BB; Kristensen B
    Br J Cancer; 1989 Aug; 60(2):252-7. PubMed ID: 2765376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer.
    Skinner JR; Wanebo HJ; Betsill WL; Wilhelm MC; Drake CR; Macleod RM
    Ann Surg; 1982 Dec; 196(6):636-41. PubMed ID: 7149814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognosis of breast cancer patients in relation to the oestrogen receptor status of both primary disease and involved nodes.
    Castagnetta L; Traina A; Carruba G; Fecarotta E; Palazzotto G; Leake R
    Br J Cancer; 1992 Jul; 66(1):167-70. PubMed ID: 1637667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
    Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour cellularity, oestrogen receptors and prognosis in breast cancer.
    Black R; Prescott R; Bers K; Hawkins A; Stewart H; Forrest P
    Clin Oncol; 1983 Dec; 9(4):311-8. PubMed ID: 6661854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer.
    Hohaus S; Funk L; Martin S; Schlenk RF; Abdallah A; Hahn U; Egerer G; Goldschmidt H; Schneeweiss A; Fersis N; Kaul S; Wallwiener D; Bastert G; Haas R
    Br J Cancer; 1999 Mar; 79(9-10):1500-7. PubMed ID: 10188897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.
    Fernandez MD; Alaghband-Zadeh J; Burn JI
    Clin Oncol; 1983 Sep; 9(3):245-50. PubMed ID: 6616999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer.
    Nicholson S; Sainsbury JR; Halcrow P; Chambers P; Farndon JR; Harris AL
    Lancet; 1989 Jan; 1(8631):182-5. PubMed ID: 2463445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of relapse and survival in breast cancer patients by pS2 protein status.
    Foekens JA; Rio MC; Seguin P; van Putten WL; Fauque J; Nap M; Klijn JG; Chambon P
    Cancer Res; 1990 Jul; 50(13):3832-7. PubMed ID: 2354435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Operable carcinoma of the breast. Prognostic value of estradiol receptors. Preliminary report (author's transl)].
    Cheix F; Biron A; Bailly C; Mayer M; Pommatau E; Saez S
    Nouv Presse Med; 1980 Mar; 9(13):933-5. PubMed ID: 7360626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.
    Hortobagyi GN; Ames FC; Buzdar AU; Kau SW; McNeese MD; Paulus D; Hug V; Holmes FA; Romsdahl MM; Fraschini G
    Cancer; 1988 Dec; 62(12):2507-16. PubMed ID: 3056604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
    Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
    Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.